Skip to content

Joseph E. Tucker

Chief Executive Officer at Enveric Biosciences.

Earliest Form D on file: May 2026

Filed May 4, 2026

Enveric Biosciences

Non-hallucinogenic neuroplasticity drugs for depression

Biotech, Cambridge MA

Signed as Chief Executive Officer

$5M

sold of $5M offered

Form D

Network

At Enveric Biosciences

6 people